NORGES BANK - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$5,560,027
-44.2%
883,947
-4.2%
0.00%
-66.7%
Q3 2022$9,968,497
-5.3%
923,0090.0%0.00%0.0%
Q2 2022$10,522,303
-44.3%
923,009
-55.5%
0.00%
-25.0%
Q1 2022$18,889,740
-22.3%
2,073,517
+27.3%
0.00%
-20.0%
Q4 2021$24,311,000
-19.6%
1,629,417
+38.6%
0.01%
-28.6%
Q3 2021$30,223,000
-26.2%
1,175,996
-25.1%
0.01%
-22.2%
Q2 2021$40,962,000
+20.9%
1,570,629
+63.6%
0.01%
+12.5%
Q1 2021$33,894,000
+18.2%
960,171
-15.5%
0.01%
+14.3%
Q4 2020$28,678,000
-38.2%
1,136,208
-7.7%
0.01%
-41.7%
Q3 2020$46,424,000
-22.7%
1,231,092
-12.2%
0.01%
-29.4%
Q2 2020$60,035,000
+195.6%
1,402,031
+34.2%
0.02%
+142.9%
Q1 2020$20,312,000
-26.6%
1,044,833
-1.9%
0.01%
-12.5%
Q4 2019$27,658,000
-0.2%
1,064,580
+4.7%
0.01%0.0%
Q3 2019$27,704,000
+39.3%
1,016,463
+37.2%
0.01%
+33.3%
Q2 2019$19,892,000
+72.0%
740,840
+85.2%
0.01%
+50.0%
Q1 2019$11,564,000
+7.4%
400,0000.0%0.00%0.0%
Q4 2018$10,772,000400,0000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders